For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole to […]

Vaccines developed at the facility will cover a wide range of respiratory diseases

The therapy becomes the first pegylated enzyme for the treatment of adult patients with Fabry disease

Researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery […]

Treatment is a lung-specific stem cell therapy designed for hospitalised patients with respiratory infections

Extensive phase 1 clinical trial evaluates safety of treatment among peritoneal patients

Candidate POLB 001 demonstrates potential in treating multiple influenza conditions

European Medicines Agency has issued a positive opinion for the use of VLA2001 among certain adults

The programme will support new European and national strategies to reduce exposure to hazardous chemicals

Pharma’s offer includes a yearly £1bn boost to the NHS and a new investment facility